Professional
Added to YB: 2024-06-07
Pitch date: 2024-06-05
TMDX [bullish]
TransMedics Group, Inc.
-43.41%
current return
Author Info
No bio for this author
Company Info
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
Market Cap
$3.3B
Pitch Price
$135.21
Price Target
151.00 (+97%)
Dividend
N/A
EV/EBITDA
29.64
P/E
23.61
EV/Sales
5.51
Sector
Health Care Equipment and Supplies
Category
growth
TransMedics Sees Street-High Price Target from Stephens, Bullish on Growth and Profitability
TMDX: Stephens initiates at Overweight with Street-high $151 PT on organ transplant device co's long-term growth & profitability potential. Well-capitalized balance sheet cited. Remains my largest position despite small trims at $140s, buying back on bounce off 21/23d EMA.
Read full article (1 min)